Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maximiliano Riddick
Observed names:
M. Riddick,
Maximiliano L. Riddick,
Riddick, Maximiliano,
Riddick, Maximiliano L.,
Riddick, Maximiliano Luis
Institution:
Universidad Nacional del Centro de la Provincia de Buenos Aires
Observed institutions:
Consejo Nacional de Investigaciones Científicas y Técnicas,
Universidad de Buenos Aires,
Universidad Nacional del Centro de la Provincia de Buenos Aires,
Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas,
Universidad Nacional de La Plata
ORCID:
0000-0002-2146-3798
Observed ORCID:
0000-0002-2146-3798
OpenAlex ID:
A5011079977
The endless quarantine: the impact of the COVID-19 outbreak on healthcare workers after three months of mandatory social isolation in Argentina
2020
·
Daniela L. Giardino
, Cristián Huck-Iriart
, et al.
·
Sleep Medicine
·
102
PET ‐adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH ‐05 trial
2019
·
Astrid Pavlovsky
, Isolda Fernandez
, et al.
·
British Journal of Haematology
·
15
Local structural investigation across the magnetic transition in the type-II multiferroic material FeVO 4
2024
·
Ganesh Bera
, Akash Surampalli
, et al.
·
Physical review. B./Physical review. B
·
12
P715: Multicenter Observational Study of Ponatinib in Cml Patients in Argentina. Real-world Experience.
2022
·
M. J. Mela Osorio
, M. V. Osycka
, et al.
·
HemaSphere
·
4
Impact of Ibrutinib in Quality of Life (QoL) in Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of Real-World Experience
2018
·
Maria Jose Mela Osorio
, Carolina Pavlovsky
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
PDF
P1081: Pet-adapted Therapy After Three Cycles of Abvd for All Stages of Hodgkin Lymphoma: Long Term Follow up of the Gatla Lh-05 Trial
2022
·
A. Pavlovsky
, N. L. Fiad
, et al.
·
HemaSphere
·
2
High Level of Successful TKI Discontinuation in Chronic Myeloid Leukemia (CML) Patients: Preliminary Results of AST-Argentina Stop Trial
2020
·
Carolina Pavlovsky
, Ana Ines Varela
, et al.
·
Blood
·
2
Mtv, Tlg and Suv Max as Promising Parameters to Predict Early Response in Patients With Hl Treated With Abvd. a Retrospective Sub‐analysis of the Gatla‐lh‐05 Trial
2021
·
J. Iorio
, M. Eleta
, et al.
·
Hematological Oncology
·
1
PDF
Estimación bayesiana en el modelo de riesgos aditivos
2020
·
Riddick, Maximiliano Luis
·
El Servicio de Difusión de la Creación Intelectual (National University of La Plata)
·
1
PDF
Review of Bayesian Analysis in Additive Hazards Model
2019
·
Alvarez, Enrique Ernesto
, Riddick, Maximiliano Luis
·
Asian Journal of Probability and Statistics
·
1
PDF
Long‐term follow‐up of PET / CT ‐adapted therapy after three cycles of ABVD for all stages of classic Hodgkin lymphoma: Results of the GATLA LH ‐05 trial
2026
·
Astrid Pavlovsky
, Lorena Fiad
, et al.
·
British Journal of Haematology
Hybrid Bayesian Estimation in the additive hazards model
2025
·
Álvarez, Enrique Ernesto
, Riddick, Maximiliano Luis
·
arXiv (Cornell University)
PDF
Stochastic approaches: modeling the probability of encounters between H$_{2}$-molecules and metallic atomic clusters in a cubic box
2023
·
Riddick, Maximiliano L.
, Álvarez, Enrique E.
, et al.
·
arXiv (Cornell University)
PDF
Impact of Ibrutinib in Quality of Life (QoL) in Patients with Chronic Lymphocytic Leukemia(CLL): Real World Experience in Argentina
2022
·
María Jose Mela Osorio
, Astrid Pavlovsky
, et al.
·
Blood
Pet‐adapted Therapy After Three Cycles of Abvd for All Stages of Hodgkin Lymphoma: Long Term Follow up of the Gatla Lh‐05 Trial
2021
·
A. Pavlovsky
, L. Fiad
, et al.
·
Hematological Oncology
PDF
In Pursuit of Surrogate Markers for Treatment-Free Remission in Patients with Chronic Myeloid Leukemia from Argentina Stop Trial
2020
·
Maria Belen Sanchez
, Beatriz Moiraghi
, et al.
·
Blood
Pb1903 Improvement in Patient‐reported Outcomes (pros) and Fatigue in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib (ibr) Monotherapy: Report of Real World Experience.
2019
·
M.J. Mela Osorio
, A. Pavlovsky
, et al.
·
HemaSphere
Brentuximab vedotin: A retrospective multicenter analysis of its indication, safety and efficacy in Argentina
2017
·
M.F. Negri Aranguren
, C. Shanley
, et al.
·
Hematological Oncology
PDF
Show more works
View as search
Works count:
20
Citation count:
143
H-index:
4
I10-index:
3
Year
Topic
Type